NLRT: Newfoundland Labrador Research Technologies

Company Introduction

Newfoundland and Labrador Research Technologies (NLRT) is a Newfoundland and Labrador company incorporated in February 2010 by Dr. Majed Khraishi. NLRT was formed to commercialize discoveries made through clinical observation and research at its sister company, Nexus Clinical Research.

This self-directed research led to proprietary methods and tools for early detection of disease and an opportunity to provide leading edge biotechnology and scientific services to the world. Specifically, this self-directed, multidisciplinary approach to research (both Dermatology and Rheumatology specialties) led to the development of screening tools for a serious diseases that often goes undiagnosed, at least until the disease has progressed significantly. These diseases are rheumatologic conditions called Psoriatic Arthritis and Rheumatoid Arthritis.

This algorithmic process employed by NLRT screening tools is patent pending. This process can be used to develop tools for early detection of many other diseases in addition to PsA and RA. Others in development include screening tools for Ankylosing Spondylitis, cardiac conditions and diabetes as well as other inflammatory diseases.

Careers

If you want to be part of us, please check the job description below and email your cover letter and resume to careers@nlrt.ca

JOB DESCRIPTION

News Release

Please check out our new applications released on MarketPlace using on Windows Phone

The Psoriatic Arthritis Screening Questionnaire (PASQ) Windows Phone version Now Available

The RADAI Windows Phone version Now Available

Home Page

Company Introduction

Careers

News Release

Release at ACR/ARHP Annual Meeting in Washington, D.C. 2012

New medical diagnostic App empowers patients

Please check out our new applications released on Apple App Store

Please check out our new applications released on MarketPlace using on Windows Phone

Our Sister Company -- Nexus Clinical Research

Check out Our Facebook